Sorbent for removing protein-bound substances

US9320845B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9320845-B2
Application numberUS-201013146003-A
CountryUS
Kind codeB2
Filing dateJan 20, 2010
Priority dateJan 22, 2009
Publication dateApr 26, 2016
Grant dateApr 26, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a sorption agent having improved selectivity properties for removing protein-bound substances from a biological fluid, in particular blood or blood plasma of patients having severe disturbances of the liver function or liver failure and having kidney insufficiency, thee sorption agent having: (a) a porous, neutral, hydrophobic polymer and (b) a polypeptide layer adsorbed on the polymer, the neutral, hydrophobic polymer having a mean pore size of at least 15 nm. Furthermore, the invention relates to methods and uses in connection with such a sorption agent. The invention is used in particular in extracorporeal liver support.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sorption agent for removing protein-bound substances from a biological fluid with reduced adsorption of Protein C, the sorption agent comprising: (a) a porous, neutral, hydrophobic polymer including microparticles, where the microparticles have a particle size of 20 μm or less and (b) a polypeptide layer adsorbed on the polymer, wherein the neutral, hydrophobic polymer is a styrene/divinyl benzene copolymer and has a mean pore size of 30-40 nm, wherein the polypeptide layer comprises at least one type of polypeptide selected from albumin, in particular human albumin, and albumin-like polypeptides, and wherein a 10% polypeptide solution is used for the adsorptive coating of the neutral, hydrophobic polymer with the polypeptide layer. 2. The sorption agent according to claim 1 , wherein the microparticles have a particle size of 1 to 9 μm. 3. A sorption apparatus for removing protein-bound substances from a biological fluid with reduced adsorption of Protein C, containing a sorption agent comprising: (a) a porous, neutral, hydrophobic polymer including microparticles, where the microparticles have a particle size of 20 μm or less and (b) a polypeptide layer adsorbed on the polymer, wherein the neutral, hydrophobic polymer is a styrene/divinyl benzene copolymer and has a mean pore size of 30-40 nm, wherein the polypeptide layer comprises at least one type of polypeptide selected from albumin, in particular human albumin, and albumin-like polypeptides, and wherein a 10% polypeptide solution is used for the adsorptive coating of the neutral, hydrophobic polymer with the polypeptide layer. 4. The sorption apparatus according to claim 3 , wherein the microparticles have a particle size of 1 to 9 μm. 5. A plasma circuit for removing protein-bound substances from a biological fluid with reduced adsorption of Protein C, containing a suspension of a sorption agent comprising: (a) a porous, neutral, hydrophobic polymer including microparticles, where the microparticles have a particle size of 20 μm or less and (b) a polypeptide layer adsorbed on the polymer, wherein the neutral, hydrophobic polymer is a styrene/divinyl benzene copolymer and has a mean pore size of 30-40 nm, wherein the polypeptide layer comprises at least one type of polypeptide selected from albumin, in particular human albumin, and albumin-like polypeptides, wherein a 10% polypeptide solution is used for the adsorptive coating of the neutral, hydrophobic polymer with the polypeptide layer. 6. The plasma circuit according to claim 5 , wherein the microparticles have a particle size of 1 to 9 μm. 7. A method for producing a sorption agent comprising: adsorptive coating a porous, neutral hydrophobic polymer with a polypeptide layer using a polypeptide solution, where the sorption agent comprises: (a) the porous, neutral, hydrophobic polymer including microparticles, where the microparticles have a particle size of 20 μm or less and (b) the polypeptide layer is adsorbed on the polymer, wherein the neutral, hydrophobic polymer is a styrene/divinyl benzene copolymer and has a mean pore size of 30-40 nm, wherein the polypeptide layer comprises at least one type of polypeptide selected from albumin, in particular human albumin, and albumin-like polypeptides, and wherein the polypeptide solution is a 10% polypeptide solution. 8. The method according to claim 7 , wherein the microparticles have a particle size of 1 to 9 μm. 9. A method for removing protein-bound substances from a biological fluid, comprising: bringing a biological fluid containing protein-bound substances into contact with a sorption agent, where the sorption agent comprises: (a) a porous, neutral, hydrophobic polymer including microparticles, where the microparticles have a particle size of 20 μm or less and (b) a polypeptide layer adsorbed on the polymer, wherein the neutral, hydrophobic polymer is a styrene/divinyl benzene copolymer and has a mean pore size of 30-40 nm, wherein the polypeptide layer comprises at least one type of polypeptide selected from albumin, in particular human albumin, and albumin-like polypeptides, and wherein a 10% polypeptide solution is used for an adsorptive coating of the neutral, hydrophobic polymer with the polypeptide layer. 10. The method according to claim 9 , wherein the biological fluid is blood or blood plasma. 11. The method according to claim 9 , where the protein-bound substances particularly being bilirubin, aromatic amino acids, bile acids, phenols, and mercaptans. 12. The method according to claim 9 , wherein the selective sorption agent is used for removing protein-bound substances from blood plasma. 13. The method according to claim 9 , wherein the selective sorption agent is used for removing protein-bound substances from blood. 14. The method according to claim 9 , wherein the selective sorption agent is used in an MDS (Microsphere-based Detoxification System). 15. The method according to claim 9 , wherein the microparticles have a particle size of 1 to 9 μm.

Assignees

Inventors

Classifications

  • comprising a cyclic structure not containing any of the heteroatoms nitrogen, oxygen or sulfur, e.g. aromatic structures · CPC title

  • derived from different types of monomers, e.g. linear or branched copolymers, block copolymers, graft copolymers · CPC title

  • consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds · CPC title

  • being in the range 2-50 nm, i.e. mesopores · CPC title

  • A61M1/3679Primary

    by absorption (A61M1/3675 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9320845B2 cover?
The invention relates to a sorption agent having improved selectivity properties for removing protein-bound substances from a biological fluid, in particular blood or blood plasma of patients having severe disturbances of the liver function or liver failure and having kidney insufficiency, thee sorption agent having: (a) a porous, neutral, hydrophobic polymer and (b) a polypeptide layer adsorbe…
Who is the assignee on this patent?
Falkenhagen Dieter, Hartmann Jens, Weber Viktoria, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61M1/3679. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).